RGC

----

Pre-market hot trades in US stocks: Regencell Bioscience up 3.48% in pre-market

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Regencell Bioscience pre-market rose 3.48%; Salarius Pharmaceuticals pre-market rose 269.72%; Scinai Immunotherapeutics pre-market rose 67.32%; Shineco pre-market rose 53.19%

Pre-market Hot Trades in US Stocks

Regencell Bioscience rose 3.48% in pre-market trading. Based on recent important news:

  1. On June 16, Regencell Bioscience completed a 38-for-1 stock split, increasing the number of circulating shares, attracting retail investors, and causing the stock price to soar by 283.13%.

  2. On June 17, social media buzz surged, attracting significant attention, and the stock price continued to rise.

  3. On June 19, circulating shares accounted for only 6% of the total share capital, resulting in low liquidity and making the stock price susceptible to manipulation.

Top Gainers in Pre-market US Stocks

Salarius Pharmaceuticals rose 269.72% in pre-market trading. Based on recent key news:

  1. On June 11, Salarius Pharmaceuticals signed a second amendment to the merger agreement with Decoy, reducing the company's valuation to $2.31 million, with original shareholders retaining 7.6% of the shares post-merger. This news significantly boosted the stock price.

  2. Following the announcement of the merger agreement amendment on June 11, market confidence in the company's future development surged, leading to a spike in the stock price.

  3. On July 24, Cubic Pharmaceuticals released a positive research report, forecasting substantial growth in the company's performance over the next few years. Although not directly related to Salarius, it reflects the overall positive sentiment in the pharmaceutical industry.

Scinai Immunotherapeutics rose 67.32% in pre-market trading. Based on recent key news:

  1. On June 5, after Italy approved the biotechnology acquisition, Scinai's stock price doubled.

  2. On July 25, the pharmaceutical sector continued to experience a "high-low cut," with funds migrating from high-valued sectors to reasonably valued tracks, driving up Scinai's stock price.

  3. On July 28, Citigroup raised target prices for companies like Kangfang Biotech and Innovent Biologics, anticipating more licensing opportunities and data catalysts in this field.

Shineco rose 53.19% in pre-market trading. Based on recent important news:

  1. On July 1, N Xintong Electronics opened with a rise of over 265%, and the market's enthusiasm for new stocks drove Shineco's stock price up.

  2. On June 25, New Henghui's intraday trading price first rose over 30%, triggering a temporary suspension, indicating strong market interest in emerging companies.

  3. On June 23, Sanhua Intelligent Control's dark market closed below the listing price, and the market's cautious attitude towards certain stocks may have prompted funds to flow into Shineco

Source: Price Alert The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.